ReviewPolymers2024
Recent Advances in Polyurethane for Artificial Vascular Application.
Review in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Electrospun Carbothane-Based Drug-Enriched Scaffolds for Cardiovascular Devices: Drug Release, Hemocompatibility, Endothelialization, and Immunological Characterization.International journal of molecular sciences · 2026Article
- Review
- Novel Magnetically Charged Grafts for Vascular Repair: Process Optimization, Mechanical Characterization and In Vitro Validation.Polymers · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Artificial blood vessels made from polyurethane (PU) have been researched for many years but are not yet in clinical use. The main reason was that the PU materials are prone to degradation after contact with blood and will also cause inflammation after long-term implantation. At present, PU has made progress in biostability and biocompatibility, respectively. The PU for artificial blood vessels still requires a balance between material stability and biocompatibility to maintain its long-term stability in vivo, which needs to be further optimized. Based on the requirement of PU materials for artificial vascular applications, this paper views the development of biostable PU, bioactive PU, and bioresorbable PU. The improvement of biostable PU from the monomer structure, chemical composition, and additives are discussed to improve the long-term biostability in vivo. The surface grafting and functionalization methods of bioactive PU to reduce thrombosis and promote endothelialization for improving biocompatibility are summarized. In addition, the bioresorbable PU for tissue-engineered artificial blood vessels is discussed to balance between the degradation rate and mechanical properties. The ideal PU materials for artificial blood vessels must have good mechanical properties, stability, and biocompatibility at the same time. Finally, the application potential of PU materials in artificial vascular is prospected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.